KMID : 1033120210100010001
|
|
´ëÇѺñ¸¸´ë»ç¿Ü°úÇÐȸÁö 2021 Volume.10 No. 1 p.1 ~ p.8
|
|
Obesity and Coronavirus Disease 2019
|
|
Kim Min-Ji
Jeon Jae-Han
|
|
Abstract
|
|
|
Obesity, which is one of the most important noncommunicable diseases, has become an epidemic. With the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, the collision of these two health risks has increased the threat of adverse events and serious threats to public health. In this review, the impact of obesity on COVID-19 severity and mortality is presented. The mechanism by which obesity increases susceptibility and severity is discussed. As a low-grade inflammatory disease, obesity provides a pro-inflammatory milieu by which adipose tissue expressing angiotensin converting enzyme 2, which is known as a receptor for severe acute respiratory syndrome coronavirus 2, works as a viral reservoir. Finally, the role of metabolic and bariatric surgeries during the COVID-19 era will be discussed.
|
|
KEYWORD
|
|
Coronavirus disease 2019, Obesity, Bariatric surgery, Angiotensin converting enzyme 2
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|